Purinoceptors in the central nervous system

Drug Development Research

Volumn 39, Issue 3-4, 1996, Pages 361-370

  Dunwiddie, T V ^b   Abbracchio, M P ^b   Bischofberger, N ^b   Brundege, J M ^b   Buell, G ^b   Collo, G ^b   Corsi, C ^b   Diao, L ^b   Kawashima, E ^b   Jacobson, K A ^b   Latini, S ^b   Lin, R C S ^b   North, R A ^b   Pazzagli, M ^b   Pedata, F ^b   Pepeu, G C ^b   Proctor, W R ^b   Rassendren, F ^b   Surprenant, A ^b   Cattabeni, F ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b NONE

Author keywords

Adenosine; Aging; ATP; Glutomate; Metabolism; Neurodegeneration; Neuroprotection; Receptors; Release; Synaptic plasticity

Indexed keywords

ADENOSINE; ADENOSINE RECEPTOR; ADENOSINE TRIPHOSPHATE; EXCITATORY AMINO ACID; GLUTAMIC ACID; PURINE P2 RECEPTOR; PURINE RECEPTOR;

BRAIN PROTECTION; CONFERENCE PAPER; HUMAN; NERVE CELL PLASTICITY; NEUROPROTECTION; NONHUMAN;

EID: 12644304249     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199611/12)39:3/4<361::AID-DDR17>3.0.CO;2-4     Document Type: Conference Paper

References (35)

1. Abbracchio MP (1997): ATP in brain function. In Jacobson K, Jarvis MF (eds): Purinergic Approaches in Experimental Therapeutics. New York: Wiley, in press.
2. Aoki E, Takeuchi IK, Shoji R (1995): Nitric oxide: An attractive signalling molecule. Acta Histochem Cytochem 2:97-106.
3. Brake AJ, Wagenback MJ, Julius D (1994): New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor. Nature 371:519-523.
4. Brundege JM, Dunwiddie TV (1996): Modulation of excitatory synaptic transmission by adenosine released from single hippocampal pyramidal neurons. J Neurosci 16:5603-5612.
5. 2x receptor expressed in epithelia and brain. EMBO J 16:55-62.
6. Buell G, Collo G, Rassendren F (1996b): P2X receptors: An emerging channel family Eur J Neurosci 8:2221-2228.
7. 2X1 receptor activation in HL60 cells. Blood 87:2659-2664.
8. Burnstock C, King BF (1996): Numbering of cloned P2 purinoceptor. Drug Dev Res 38:67-71.
9. Ceruti S, Barbieri D, Franceschi C, et al. (1996): Effects of adenosine A3 receptor agonists on astrocytes: induction of cell protection at low and cell death at high concentrations. Drug Dev Res 3:177
10. Chen C-C, Akopian AN, Sivilotti L, Colquhoun D, Burnstock G, Wood JN (1995): A P2X purinoceptor expressed by a subset of sensory neurons. Nature 377:428-431.
11. Collingridge GL, Ileroh CE, Lester RAJ (1988): Frequency-dependent N-methyl-D-aspartate receptor-mediated synaptic transmission in rat hippocampus. J Physiol 399:301-312.
12. 6 receptors, and the distribution and properties of an extended family of ATP-gated ion channels. J Neurosci 16:2495-2507.
13. Corradetti R, Lo Conte G, Moroni F, Passani MB, Pepeu G (1984): Adenosine decreases aspartate and glutamate release from rat hippocampal slices Eur J Pharmacol 104:19-26.
14. Corsi C, Pazzagli M, Bianchi L, Della Corte L, Pepeu G, Pedata F (1997): In vivo amino acid release from the striatum of aging rats adenosine modulation. Neurobiol Aging, in press.
15. 3H]acetylcholine release from different areas of the rat hippocampus. J Neurochem 63:207-214.
16. 2a adenosine receptor binding in aged striatum, hippocampus and cortex of the rat. NeuroReport 6:1583-1588.
17. 2 receptors but have potent pharmacological activity in vivo. Biochem Pharmacol 35:3021-3029.
18. Dawson TM, Snyder SH (1994): Gases as biological messengers: nitric oxide and carbon monoxide in the brain. J Neurosci 9:5147-5159
19. Di Virgilio F, Ferrari D, Chiozzi P, Falzoni S, Sanz JM, Susino M, Mutini C, Hanau S, Baricordi OR (1996): Purinoceptor function in the immune system. Drug Dev Res 39:319-329.
20. Dunwiddie TV, Lynch GS (1978): Long-term potentiation and depression of synaptic responses in the rat hippocampus: localization and frequency dependency. J Physiol 276:353-367.
21. Edwards FA, Gibb AJ, Colquhoun D (1992): ATP receptor-mediated synaptic currents in the central nervous system. Nature 359:144-147.
22. Evans RJ, Derkach V, Surprenant A (1992): ATP mediates fast synaptic transmission in mammalian neurons. Nature 357:503-505.
23. Fozard JR, Pfankuche HJ, Schuurman HJ (1996): Mast cell degranulation following adenosine A3 receptor activation in rats. Eur J Pharmacol 298:293-297.
24. Franceschi C, Abbracchio MP, Barbieri D, Ceruti S, Ferrari D, Iliou JP, Rounds S, Schubert P, Lohoff ES, Rassendren FA, Staub M, Volonte C (1996): Purines and cell death. Drug Dev Res 39:442-449.
25. Giovannelli L, Giovannlni MG, Pedata F, Pepeu G (1988): Purinergic modulation of cortical acetylcholine release is decreased in aging rats. Exp Gerontol 23:175-181.
26. Tschopl M, Harms L, Norenberg W, Illes P (1992): Excitatory effects of adenosine 5′-triphosphate on rat locus coeruleus neurones. Eur J Pharmacol 213:71-77.
27. 2X receptor for extracellular ATE Nature 371:516-519.
28. von Lubitz DKJE, Diemer NH (1982): Ultrastructural morphometry of the stratum radiatum in the CA 1 region of the rat hippocampus. Pol Neuropathol 1982:Suppl 1.
29. von Lubitz DKEJ, Dambrosia JM, Redmond DJ (1989): Protective effect of cyclohexyladenosine in treatment of cerebral ischemia in gerbils. Neuroscience 30:451-162.
30. 3 receptor stimulation and cerebral ischemia. Eur J Pharmacol 263:59-67.
31. von Lubitz DKJE, Carter ME Beenhakker M, Lin RC-S, Jacobson KA (1995a): Adenosine: A prototlierapeutic concept in neurodegeneration. Ann NY Acad Sci 765:163-178
32. 3 receptor stimulation on seizures in mice. Eur J Pharmacol 275:23-29.
33. 3 receptors and ischemic brain injury: A hope or a disaster? Drug Dev Res 37:140.
34. 2X receptors) determined by immunocytochemistry. Proc Natl Acad Sci USA 93:8063-8067.
35. Williams M (1989): Adenosine: The prototype neuromodulator. Neurochem Int 14:249-264.